J. Tedroff et al., L-DOPA MODULATES STRIATAL DOPAMINERGIC FUNCTION IN-VIVO - EVIDENCE FROM PET INVESTIGATIONS IN NONHUMAN-PRIMATES, Synapse, 25(1), 1997, pp. 56-61
Significant increases in striatal L-[C-11]DOPA retention were observed
in adult female rhesus monkeys with positron emission tomography (PET
) following administration of drugs that increase cerebral L-DOPA conc
entrations. The monkeys were scanned twice: at baseline (using 10-50 m
u g of tracer substance) and during continuous administration of L-DOP
A (3 or 15 mg/kg/h) and 6-R-Erythro-4,5,6,7-tetrahydrobiopterin (6R-BH
4) (5 mg/kg/h) and during combined administration of both drugs. PET s
cans of L-[C-11]DOPA distribution were obtained in GE2048-15B or GE409
6-15WB Plus positron tomographs. In all studies the specific striatal
L-[C-11]DOPA influx rate increased by an average of 17-20%. These incr
eases were significantly higher than the retest variability obtained w
ith saline infusions under identical experimental conditions. In indiv
idual monkeys the magnitude of increase in the striatal L-[C-11]DOPA i
nflux rate varied from no effect of the drug infusion to a 45% increas
e. Taken together, the results of this study demonstrate that L-DOPA i
n itself can affect dopaminergic neurotransmission in vivo and also ad
ds further evidence that the neuromodulatory effects of the amino acid
are predominantly autoreceptor antagonist-like, The findings most lik
ely have importance for the further understanding of the dopaminergic
system in neurodegenerative and psychiatric disorders. (C) 1997 Wiley-
Liss, Inc.